Dermot Ryan

Expert Perspectives on Next Generation Health Guidelines: How to Integrate RWE in EBM

Promoting Prevention and Targeting Remission of Asthma

EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care

Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study

Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group

Clinical review: The suggested management pathway for urticaria in primary care

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA²LEN consensus

Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients

European Position Paper on Rhinosinusitis and Nasal Polyps 2020

Real‐life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA

Potential Severe Asthma Hidden in UK Primary Care

Hormone replacement therapy and asthma onset in menopausal women: National cohort study

Hormonal contraceptives and onset of asthma in reproductive-age women: Population-based cohort study

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

Hormonal contraception and the risk of severe asthma exacerbation: 17-year population-based cohort study

<p>The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients</p>

Beliefs and preferences regarding biological treatments for severe asthma

<p>A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD</p>

Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

2019 ARIA Care pathways for allergen immunotherapy

The role of mobile health technologies in allergy care: An EAACI position paper

Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

Management of ocular allergy

ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions

The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group

EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis

A multinational observational study identifying primary care patients at risk of overestimation of asthma control

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology